Qing Guo

机构：People 's Hospital of Jilin Province · ORCID：0000-0002-4725-0424

发表论文 64 篇 · 总被引 1013 次 · h-index 18

代表论文

• Antibody seroprevalence in the epicenter Wuhan, Hubei, and six selected provinces after containment of the first epidemic wave of COVID-19 in China (2021 · The Lancet Regional Health - Western Pacific · 被引 57)
• Predictors of HBsAg seroclearance in patients with chronic HBV infection treated with pegylated interferon-α: a systematic review and meta-analysis (2024 · Hepatology International · 被引 33)
• Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients (2022 · Frontiers in Cellular and Infection Microbiology · 被引 22)
• External Validation of aMAP Hepatocellular Carcinoma Risk Score in Patients With Chronic Hepatitis B-Related Cirrhosis Receiving ETV or TDF Therapy (2021 · Frontiers in Medicine · 被引 21)
• A simple-to-use tool for predicting response to peginterferon in HBV DNA suppressed chronic hepatitis B patients in China (2021 · Antiviral Research · 被引 17)
• The potential effect of HBV vaccination on off-treatment HBsAg reversion after interferon-induced HBsAg clearance (2023 · Human Vaccines & Immunotherapeutics · 被引 10)